Shape the future of CNS drug development at Lundbeck
As Principal Scientist – in vitro Drug-Drug Interaction (DDI), you will play a key role in the evaluation and prediction of DDI risks for Lundbeck’s development compounds, ensuring safe and effective therapies reach patients.
You will design, conduct, and interpret in vitro DDI studies, develop PBPK models, and guide decision-making in both preclinical and clinical development.
This is a senior scientific position where you will influence Lundbeck’s innovative CNS pipeline and collaborate across functions to secure the highest scientific standards.
Qualification Requirements
Preferred Qualifications and Attributes
We are seeking a robust, resilient, and perseverant scientist who thrives on scientific challenges and collaborative teamwork.
You are proactive, quality-focused, and committed to delivering results that make a real difference for patients.
Location: Valby, Copenhagen Denmark I On site: At least 4 days/week.
About Lundbeck
Lundbeck is a global pharmaceutical company dedicated to restoring brain health so every person can be their best.
For more than 70 years, they have been at the forefront of discovering, developing, and delivering innovative medicines for people living with psychiatric and neurological disorders.
Lundbeck pride themselves on scientific excellence, collaboration, and a deep commitment to improving lives.
Please read more at https://www.lundbeck.com/global
Please apply through haegercarlsson.com.
Questions are answered by:
Alexander Johansson, +46 (0)73 – 77 77 233, alexander@haegercarlsson.com
Rolf Carlsson, +46 (0)70-316 12 68, rolf@haegercarlsson.com